Buprenorphine And Naloxone Tablet
Product Images NDC 0121-1018

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0121-1018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pharmaceutical Associates, Inc. And Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride)

HCI stands for Human-Computer Interaction. It is a field that focuses on the design, evaluation, and implementation of interactive computing systems for human use. HCI combines principles and methods from computer science, psychology, anthropology, and other disciplines to study how humans interact with computers and how to design technology that is user-friendly and efficient. HCI encompasses a wide range of topics, including user interface design, usability testing, user experience, and accessibility. Its goal is to improve the interaction between humans and computers, making technology more intuitive and accessible for all users.*

FDA Label Image

Chemical Structure (Naloxone Hydrochloride Dihydrate)

FDA Label Image

Figure 3 (Buprenorphine Naloxone 03)

FDA Label Image

2 mg/0.5 mg Sublingual Tablet 30-count Bottle Label (Buprenorphine Naloxone 04)

The description is as follows: "Each tablet contains Buprenorphine and Naloxone. The tablets are manufactured by Ethypharm S.A in France and distributed by PA| Pharma. The tablets are sublingual and are available in a 2mg/0.5mg dosage. The usual dosage should be determined based on the product information. The tablets should be stored at a temperature of 20°C to 25°C. The medication guide is available for dispensing to each patient. The tablets should be kept out of reach of children. The GTIN (Global Trade Item Number) is 0301211018304."*

FDA Label Image

8 mg/2 mg Sublingual Tablet 30-count Bottle Label (Buprenorphine Naloxone 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.